Dr. Hugh Levaux, Former CEO of Ninaza, Joins Medidata Solutions as Vice President of Product Strategy



    Pharma Industry Veteran to Manage Medidata's Product Offerings and Create
New Market Opportunity for Rave(R)

    NEW YORK, April 10 /CNW/ - Medidata Solutions, a global provider of
electronic clinical data capture, management and reporting solutions, today
announced the addition of Dr. Hugh Levaux as vice president of product
strategy. In this role, Levaux will draw on more than 15 years of experience
in pharmaceutical outsourcing, strategic consulting and health outcomes
research, as well as expertise in early phase clinical development, late phase
registries and safety surveillance programs. Levaux will be responsible for
the overall definition and management of Medidata's product offerings, working
to bring together Medidata Rave implementation, hosting and support services
to address new and existing market segments and customer requirements.

    Levaux joins Medidata from Ninaza, a recent provider of web-based
electronic data capture (EDC) solutions. As CEO of Ninaza, he set strategic
direction for the company and oversaw daily operations with a specific focus
on product development, commercial operations and professional services. Prior
to joining Ninaza, Levaux held positions as vice president and general manager
of the pharmaceutical/biotechnology practice at CareScience, a supplier of
web-based patient database and analysis software. He also previously served as
senior vice president at Quintiles Transnational, directing international late
phase sales and clinical operations.

    "I am very excited to apply my experience in EDC technology, professional
services and product development to my new role at Medidata, a company that
has been consistently driving the evolution of the e-clinical process," Levaux
said. "Medidata's innovation and advancements - from both a technology and
services perspective - continue to make a significant impact on the way
sponsors conduct clinical trials. I look forward to collaborating with a
talented team that is committed to customer success to create new market
opportunities for Rave."

    Prior to Quintiles, Levaux worked as an analyst for RAND Corporation,
where he performed risk assessment on emerging markets and evaluated the
adoption of commercial processes and technologies with government and private
sector clients. Levaux holds a Ph.D. in policy analysis from the RAND Graduate
School and has also received master's degrees in international economics and
international relations from SAIS at Johns Hopkins University and
international politics from Universite Libre de Bruxelles in Belgium.
Additionally, Levaux's work has been published in leading academic and
clinical journals.

    "With our launch of Medidata Rave 5.6 earlier this year, Hugh's ability
to implement strategic product initiatives will be invaluable as we continue
to meet increasing market demand for Rave and for our expertise in clinical
software integration," said Glen de Vries, chief technology officer of
Medidata Solutions. "Hugh's experience will help us shape how we develop new
features in Rave and add critical services that will allow us to approach new
customers and enter new markets. We are excited for Hugh to join Medidata, and
see his addition to the team as a reflection of the high quality products and
services we provide as well as the appeal of our skilled leadership team."

    About Medidata Solutions Worldwide

    Medidata Solutions helps the world's leading pharmaceutical,
biotechnology, medical device and research organizations maximize the value of
their clinical research investments. Innovative process design, technology and
services streamline clinical trials by providing early visibility to reliable
clinical data - the lifeblood of every research organization. Working with
companies and institutions both large and small, Medidata Solutions helps
clinical researchers safely accelerate the process of bringing life-enhancing
treatments to market - on six continents and in more than 80 countries.
Medidata Solutions brings significant value to its broad client base with deep
clinical experience and expertise in more than 20 therapeutic areas, projects
in Phase I, II, III, IV, registries and surveillance, and studies with
thousands of investigators and tens-of-thousands of subjects. For more
information, please visit www.mdsol.com.




For further information:

For further information: Lois Paul & Partners Susan Lombardo,
781-782-5767 Susan_Lombardo@lpp.com

Organization Profile

MEDIDATA SOLUTIONS WORLDWIDE

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890